已收录 268921 条政策
 政策提纲
  • 暂无提纲
Anti‐JAM‐C therapy eliminates tumor engraftment in a xenograft model of mantle cell lymphoma
[摘要] Junctionaladhesionmolecule(JAM)‐CisamemberoftheJAMfamily,expressedbyavarietyofdifferentcelltypes,includinghumanBlymphocytesandsomeB‐celllymphomasubtypes—inparticular,mantlecelllymphoma(MCL).Treatmentwithanti‐JAM‐CpAbsreduceshomingofhumanBcellstolymphoidorgansinaNOD/SCIDmousemodel.Inthepresentstudy,theroleofJAM‐CintheengraftmentofhumanlymphomaBcellsinmicewasinvestigated.Administrationofnovelanti‐JAM‐CmAbsreducedtumorgrowthofJAM‐C+MCLcellsinbonemarrow,spleen,liver,andlymphnodesofmice.Treatmentwithanti‐JAM‐CantibodiessignificantlyreducedtheproliferationofJAM‐C‐expressinglymphomaBcells.Moreover,thebindingofanti‐JAM‐CantibodiesinhibitedthephosphorylationofERK1/2,withoutaffectingothersignalingpathways.TheresultsidentifyforthefirsttimetheintracellularMAPKcascadeastheJAM‐C‐drivensignalingpathwayinJAM‐C+Bcells.TargetingJAM‐CcouldconstituteanewtherapeuticstrategyreducinglymphomaB‐cellproliferationandtheircapacitytoreachsupportivelymphoidmicroenvironments...
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生理学
[关键词] B‐cell homing;B‐cell proliferation;mantle cell lymphoma treatment [时效性] 
   浏览次数:12      统一登录查看全文      激活码登录查看全文